Clinical performance of a new lateral flow immunoassay for xylazine detection
XYL500 allows for rapid detection of xylazine, illustrating its utility in monitoring patients who ingested recreational drugs containing the additive, xylazine, and its potential to improve patient management.
Authors
- Marion L. Snyder
- Phillip Kang
- Stacy E.F. Melanson (ORCID: https://orcid.org/0000-0002-4209-6085)
- Nicole V. Tolan (ORCID: https://orcid.org/0000-0002-7239-1843)
- Lindsey Contella (ORCID: https://orcid.org/0009-0004-8549-5299)
Institutions
- Brigham and Women's Hospital (US)
- Harvard University (US)
Publication Details
- Journal
- Clinical Chemistry and Laboratory Medicine (CCLM)
- Published
- 2024-10-11
- DOI
- https://doi.org/10.1515/cclm-2024-0947
- Citations
- 4
- Primary Topic
- Veterinary Pharmacology and Anesthesia
- Type
- article
- Field-Weighted Citation Impact
- 2.55